JPH11335266A5 - - Google Patents

Info

Publication number
JPH11335266A5
JPH11335266A5 JP1999129990A JP12999099A JPH11335266A5 JP H11335266 A5 JPH11335266 A5 JP H11335266A5 JP 1999129990 A JP1999129990 A JP 1999129990A JP 12999099 A JP12999099 A JP 12999099A JP H11335266 A5 JPH11335266 A5 JP H11335266A5
Authority
JP
Japan
Prior art keywords
polyoxyethylene
polyoxyethylene fatty
weight
nanodispersion
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999129990A
Other languages
English (en)
Japanese (ja)
Other versions
JP4755742B2 (ja
JPH11335266A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH11335266A publication Critical patent/JPH11335266A/ja
Publication of JPH11335266A5 publication Critical patent/JPH11335266A5/ja
Application granted granted Critical
Publication of JP4755742B2 publication Critical patent/JP4755742B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP12999099A 1998-05-11 1999-05-11 医薬最終処方物におけるナノディスパージョンの使用 Expired - Lifetime JP4755742B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810422 1998-05-11
EP98810422.0 1998-05-11

Publications (3)

Publication Number Publication Date
JPH11335266A JPH11335266A (ja) 1999-12-07
JPH11335266A5 true JPH11335266A5 (cg-RX-API-DMAC10.html) 2006-06-22
JP4755742B2 JP4755742B2 (ja) 2011-08-24

Family

ID=8236078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12999099A Expired - Lifetime JP4755742B2 (ja) 1998-05-11 1999-05-11 医薬最終処方物におけるナノディスパージョンの使用

Country Status (20)

Country Link
US (2) US7081253B2 (cg-RX-API-DMAC10.html)
EP (1) EP0956853B1 (cg-RX-API-DMAC10.html)
JP (1) JP4755742B2 (cg-RX-API-DMAC10.html)
KR (1) KR100622285B1 (cg-RX-API-DMAC10.html)
CN (1) CN1220483C (cg-RX-API-DMAC10.html)
AR (1) AR019274A1 (cg-RX-API-DMAC10.html)
AT (1) ATE312597T1 (cg-RX-API-DMAC10.html)
AU (1) AU767896B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI9902068B8 (cg-RX-API-DMAC10.html)
CZ (1) CZ166999A3 (cg-RX-API-DMAC10.html)
DE (1) DE59912910D1 (cg-RX-API-DMAC10.html)
ES (1) ES2253871T3 (cg-RX-API-DMAC10.html)
HU (1) HUP9901570A2 (cg-RX-API-DMAC10.html)
ID (1) ID22565A (cg-RX-API-DMAC10.html)
MY (1) MY133019A (cg-RX-API-DMAC10.html)
PL (1) PL332934A1 (cg-RX-API-DMAC10.html)
RU (1) RU2224505C2 (cg-RX-API-DMAC10.html)
SG (1) SG71923A1 (cg-RX-API-DMAC10.html)
TW (1) TWI241915B (cg-RX-API-DMAC10.html)
ZA (1) ZA993200B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908309D0 (en) * 1999-04-12 1999-06-02 Phares Pharm Res Nv Lipid aggregate forming compositions and their use
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
RU2200558C1 (ru) * 2002-04-23 2003-03-20 Нестерук Владимир Викторович Лекарственное средство, содержащее финастерид
AT6609U3 (de) * 2003-04-07 2004-04-26 Unipack Ges M B H Abfuell Und Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
PL1768650T3 (pl) * 2004-06-04 2009-01-30 Camurus Ab Ciekłe formulacje depot
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
EP2013016B8 (en) 2006-03-29 2014-10-08 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP4840031B2 (ja) 2006-08-31 2011-12-21 ソニー株式会社 ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CL2008000037A1 (es) * 2007-01-16 2008-10-10 Bayer Consumer Care Ag Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
CN100536826C (zh) * 2007-12-28 2009-09-09 清华大学 一种绵羊油纳米乳液及其制备方法和应用
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
FR2949063B1 (fr) * 2009-08-11 2011-09-30 Pf Medicament Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
CN102277748A (zh) * 2010-06-12 2011-12-14 罗莱家纺股份有限公司 纳米维生素微胶囊整理剂的使用方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP3583954A1 (en) * 2018-06-19 2019-12-25 neubourg skin care GmbH Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
US12171729B2 (en) 2019-11-25 2024-12-24 The Johns Hopkins University Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors
CN111388744B (zh) * 2020-01-15 2021-05-18 华中科技大学 一种凝胶贮库及其制法与制备术后止血制剂的应用
BR112022015829A2 (pt) * 2020-02-11 2022-10-25 Advent Therapeutics Inc Composições de palmitato de vitamina a, processos para sua preparação, usos e métodos que as compreendem
WO2021233967A1 (en) * 2020-05-20 2021-11-25 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
WO2021247542A2 (en) * 2020-06-01 2021-12-09 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
KR102628523B1 (ko) 2020-06-30 2024-01-24 주식회사 종근당 GnRH 유도체를 포함하는 주사용 조성물
WO2024165166A1 (en) 2023-02-10 2024-08-15 Tetra Pharm Technologies A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150990A1 (de) 1981-12-23 1983-06-30 A. Nattermann & Cie GmbH, 5000 Köln Neue pflanzenschutzmittelsuspensionskonzentrate
US4675193A (en) * 1983-10-31 1987-06-23 Borden, Inc. Cheese-flavored substance and method of producing same
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
CA1321144C (en) 1986-08-07 1993-08-10 Henrich H. Paradies Pharmaceutical preparations
DE3852409T2 (de) 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
EP0349150B1 (en) * 1988-06-20 1994-08-17 Shiseido Company Limited Transparent compostition
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
CH677886A5 (cg-RX-API-DMAC10.html) * 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
DK0597007T3 (da) * 1991-07-26 1996-11-18 Smithkline Beecham Corp V/O mikroemulsioner
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH685674A5 (de) 1993-12-19 1995-09-15 Marigen Sa Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen.
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733372A3 (de) * 1995-03-21 1998-05-20 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
DE19522693A1 (de) 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
JP3508314B2 (ja) * 1995-08-18 2004-03-22 大正製薬株式会社 ビタミンcを配合した液剤
WO1997021428A1 (de) * 1995-12-12 1997-06-19 Vesifact Ag Cortisolspray zur topischen verabreichung
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
DE59710082D1 (de) * 1996-12-13 2003-06-18 Vesifact Ag Baar Kosmetische Präparate in Form einer Nanodispersion
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Similar Documents

Publication Publication Date Title
RU2406522C2 (ru) Способ уменьшения воспаления ткани ротовой полости с использованием экстракта магнолии
ES2239010T3 (es) Extractos de chrysanthemum matricaire (tanacetum parthenium) utilizados contra los trastornos inflamatorios.
RU99109958A (ru) Использование нано-дисперсий в составах для фармацевтического применения
JPH11335261A5 (cg-RX-API-DMAC10.html)
WO1993000873A1 (en) Composition and method for transdermal delivery of diclofenac
JP2002534377A5 (cg-RX-API-DMAC10.html)
US20120213717A1 (en) Soothing Agents
HUE027474T2 (en) nasal Spray
BRPI9811989B1 (pt) uso do ácido 9-cis retinóico para a fabricação de um medicamento
ATE455539T1 (de) Darreichungsformen mit verlängerter wirkstofffreisetzung
JPS60152413A (ja) メントールにより経皮性薬剤放出の強化を行なつた局所用組成物
JP2018522050A (ja) 経鼻組成物
JP2005511650A5 (cg-RX-API-DMAC10.html)
HU218921B (hu) Stroncium (II) valamely szervetlen sója topikális alkalmazása neurogén eredetű bőrelváltozások kezelésére alkalmas gyógyszerkészítmények előállítására
US20120263660A1 (en) Hair Loss Treatment
CN100398090C (zh) 包含蜂胶作为活性物质的四元组合物
JP5643872B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JPH0774152B2 (ja) 皮膚外用液剤
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2001278750A (ja) 新規育毛剤
CN114452229A (zh) 一种含有青蒿素的皮肤护理组合物
RU2469704C1 (ru) Сыворотка "регенерин" для наружного применения с противовоспалительным и регенерирующим эффектом
CN101468055A (zh) 一种预防与治疗脑血栓的凝胶贴剂及其制备方法
JP5993336B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物